期刊文献+

乙肝病毒表面抗原浓度与恶性肿瘤患者肝功能损伤的相关性

The correlation between the concentration of hepatitis B virus surface antigen and liver function damage in patients with malignant tumors
下载PDF
导出
摘要 目的:探讨乙肝病毒表面抗原(HBsAg)浓度与α-L-岩藻糖苷酶(AFU)、甲胎蛋白(AFP)、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、γ-谷氨酰基转移酶(γ-GGT)、碱性磷酸酶(ALP)及乳酸脱氢酶(LDH)在恶性肿瘤中的相关性。方法:收集2019年06月01日到2020年05月31日期间我院81例HBsAg阳性住院肿瘤患者及同期81名健康体检者肝功能检测指标。应用SPSS 20.0统计学软件分析HBsAg阳性在恶性肿瘤中的意义。结果:HBsAg阳性组与对照组AFU、AFP、ALT、AST、γ-GGT、ALP及LDH比较差异有统计学意义(P<0.05)。HBsAg浓度在性别、肿瘤类型中差异无统计学意义(P>0.05),在年龄和分期中存在统计学差异(P<0.05)。根据HBsAg浓度将肿瘤组分为0.03~25.00 IU/mL、25.01~250.00 IU/mL、250.01~2500.00 IU/mL及>2500.00 IU/mL四组,0.03~25.00 IU/mL组AFP、AST与HBsAg呈正相关(r=0.654,0.501,P<0.05),>2500.00 IU/mL组AFU、AFP、AST与HBsAg呈正相关(r=0.527,0.524,0.476,P<0.05),25.01~250.00 IU/mL、250.01~2500.00 IU/mL组各项与HBsAg浓度之间无相关性(P>0.05);各组AFP阳性率随HBsAg浓度升高无升高趋势(P>0.05),而AFU阳性率随HBsAg浓度升高呈升高趋势(P<0.05)。HBsAg、HBeAg和HBcAb三项阳性组与AFU呈正相关(r=0.516,P<0.05),HBsAg和HBcAb两项阳性组与ALP呈正相关(r=0.567,P<0.05)。结论:HBsAg阳性在肿瘤患者肝功能损伤及疾病的严重程度或进展评估方面有一定的临床参考价值。 Objective:To investigate the relationship between the concentration of hepatitis B virus surface antigen(HBsAg)andα-L-fucosidase(AFU),alpha-fetoprotein(AFP),alanine aminotransferase(ALT),aspartate aminotransferase(AST),γ-glutamyltransferase(γ-GGT),alkaline phosphatase(ALP)and lactate dehydrogenase(LDH)in malignant tumors.Methods:From June 1,2019 to May 31,2020,the liver function test indicators of 81 HBsAg-positive malignant tumor patients and 81 healthy subjects in the same period were collected in our hospital.SPSS 20.0 statistical software was used to analyze the significance of HBsAg positive in malignant tumors.Results:There was a statistically significant difference in AFU,AFP,ALT,AST,γ-GGT,ALP and LDH compared with the control group(P<0.05).There was no statistical difference in HBsAg concentration in gender and tumor classification(P>0.05),and there were statistical differences in age and stage(P<0.05).According to the HBsAg concentration,the tumor components were 0.03~25.00 IU/mL,25.01~250.00 IU/mL,250.01~2500.00 IU/mL and>2500.00 IU/mL four groups,the 0.03~25.00 IU/mL group AFP,AST and HBsAg were positive correlation(r=0.654,0.501,P<0.05),and AFU,AFP,AST were positively correlated with HBsAg in>2500.00 IU/mL group(r=0.527,0.524,0.476,P<0.05),and there were none correlation between HBsAg and other parameters in 2nd and 3rd group(P>0.05).The positive rate of AFP showed no increasing trend with the increase of HBsAg concentration(P>0.05),while the positive rate of AFU showed an increasing trend with the increase of HBsAg concentration(P<0.05).The three positive groups of HBsAg,HBeAg and HBcAb were positively correlated with AFU(r=0.516,P<0.05),and the HBsAg positive group was positively correlated with ALP(r=0.567,P<0.05).Conclusion:There is a certain correlation between HBsAg concentration and liver function damage in assessing the severity of the disease in cancer patients,and has certain clinical value for disease monitoring.
作者 徐伟 周晓 袁志敏 XU Wei;ZHOU Xiao;YUAN Zhimin(Department of Blood Transfusion,Chaohu Hospital of Anhui Medical University,Anhui Chaohu 238000,China;Department of Outpatient,971 Hospital of Navy,Shandong Qingdao 266000,China;Clinical Laboratory,Shaanxi Provincial Cancer Hospital,Shaanxi Xi'an 710061,China.)
出处 《现代肿瘤医学》 CAS 北大核心 2021年第13期2305-2308,共4页 Journal of Modern Oncology
基金 国家自然科学基金(编号:81702643)。
关键词 HBSAG 恶性肿瘤 相关性分析 HBsAg malignant tumor correlation analysis
  • 相关文献

参考文献7

二级参考文献38

  • 1李宇红,何义富,王风华,林旭滨,夏忠军,孙晓非,林桐榆,黄慧强,张力,徐瑞华,姜文奇,管忠震.116例携带乙肝病毒的淋巴瘤患者化疗后发生肝功能损害的临床分析[J].癌症,2005,24(12):1507-1509. 被引量:24
  • 2彭文伟.传染病学(第4版)[M].北京:人民卫生出版社,1997.49.
  • 3Faggioli P, De Paschale M, Tocci A, et al.Acute hepatictoxicity during cyclic chemotherapy in non-Hodgkin,slymphoma. Haematologica,1997,82:28.
  • 4Farrow AC,Buchanan GR,Zwiener RJ,et al. Serumaminotransferase elevation during and following treatment of chidhood acute lymphoblastic leukemia. J Clin Oncol,1997,15:1560.
  • 5Maguire CM.Case report:Lamivudine therapy for submassive hepaticnecrosis due to reactivation of hepatitis B following chemotherapy.J Gastroenterol Hepatol,1999,14:801-803.
  • 6Steinberg JL.Hepatitis B virus reactivation in patients undergoingcytotoxic chemotherapy for solid tumours: precore/ core mutations may play animportant role. J Med Virol, 2000,60:249-255.
  • 7FuminakaSugauchi,YasuhitoTanaka,ShigeruKusumoto,KentaroMatsuura,MasayaSugiyama,FuatKurbanov,RyuzoUeda,MasashiMizokami.Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy[J].J Med Virol.2011(3)
  • 8KoseiMatsue,Shun‐IchiKimura,YokoTakanashi,Kan‐IchiIwama,HideakiFujiwara,MasayukiYamakura,MasamiTakeuchi.Reactivation of hepatitis B virus after rituximab‐containing treatment in patients with CD20‐positive B‐cell lymphoma[J].Cancer.2010(20)
  • 9Masaya Sugiyama,Yasuhito Tanaka,Fuat Kurbanov,Isao Maruyama,Takashi Shimada,Satoru Takahashi,Tomoyuki Shirai,Keisuke Hino,Isao Sakaida,Masashi Mizokami.Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes[J].Gastroenterology.2009(2)
  • 10H.L.Zaaijer,P.Torres,A.Onta?ón,L. GonzálezPonte,M.H.G.M.Koppelman,P.N.Lelie,F.J.vanHemert,H.J.Boot.Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection[J].J Med Virol.2008(8)

共引文献3408

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部